As policymakers and stakeholders consider changes to the 340B Drug Pricing Program, questions remain about how upcoming policy decisions could affect patients’ access to medications, care, and other services.

The NHC invites you to a webinar to ask questions, learn about changes to 340B under consideration, and discuss their potential implications for patients. The webinar will provide objective information to help NHC members navigate this complex issue and determine where a shared patient perspective may be most helpful.

Agenda:

• • Introduction 
  • Bills overview
  • Reactor panel discussion 
  • Q&A 

Panelists:

• • Moderator: Jennifer Dexter, Vice President, Policy, National Health Council
  • Anna Hyde, Vice President of Advocacy and Access, Arthritis Foundation
  • Sally Greenberg, JD, Chief Executive Officer, National Consumers League
  • Patrick Wildman, Senior Vice President, Advocacy & Government Relations, Lupus Foundation of America
  • Kenneth Finegold, Senior Vice President of Research and Policy, National Pharmaceutical Council
  • Patrick Brennan, Associate, Mannatt Health

Thank You to Our Supporters
The National Health Council recognizes the generous support of organizations that partner with us to advance patient-centered policy, education, and engagement on behalf of patients.

For those who are unable to attend, we will share a link with the recording afterwards.